Veradigm Inc.
US ˙ OTCPK ˙ US01988P1084

Introduction

This page provides a comprehensive analysis of the known insider trading history of Michael Klayko. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Michael Klayko has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:MDRX / Veradigm Inc. Director 38,581
US:CONE / CyrusOne Inc Director 8,986
US:PMCS / PMC - Sierra, Inc. Director 0
US:BYI / Director 0
US:BRCD / Brocade Communications Systems, Inc. Chief Executive Officer, Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Michael Klayko. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases MDRX / Veradigm Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in MDRX / Veradigm Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2014-11-11 MDRX KLAYKO MICHAEL 5,000 11.2600 5,000 11.2600 56,300 253 15.1600 19,500 34.64
2014-08-18 MDRX KLAYKO MICHAEL 3,500 14.4100 3,500 14.4100 50,435
2014-06-13 MDRX KLAYKO MICHAEL 4,000 12.5200 4,000 12.5200 50,080
2013-08-15 MDRX KLAYKO MICHAEL 10,000 14.8000 10,000 14.8000 148,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MDRX / Veradigm Inc. Insider Trades
Insider Sales MDRX / Veradigm Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in MDRX / Veradigm Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2021-06-08 MDRX KLAYKO MICHAEL 28,000 18.0340 28,000 18.0340 504,952 141 13.19 -135,632 -26.86
2021-06-04 MDRX KLAYKO MICHAEL 113,000 18.0010 113,000 18.0010 2,034,113

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MDRX / Veradigm Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Michael Klayko as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-06-09 2021-06-08 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
S - Sale -28,000 38,581 -42.05 18.03 -504,952 695,770
2021-06-04 2021-06-04 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
S - Sale -113,000 66,581 -62.92 18.00 -2,034,113 1,198,525
2021-05-27 2021-05-25 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 12,056 179,581 7.20
2020-05-22 2020-05-21 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 30,582 162,525 23.18
2020-05-08 2020-05-08 4 CONE CyrusOne Inc.
Common Stock
S - Sale -5,515 8,986 -38.03 73.60 -405,926 661,375
2020-05-04 2020-04-30 4 CONE CyrusOne Inc.
Common Stock
A - Award 2,139 14,426 17.41
2019-05-29 2019-05-24 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 19,628 136,943 16.73
2019-03-11 2019-03-11 4 CONE CyrusOne Inc.
Common Stock
P - Purchase 1,955 12,016 19.43 51.10 99,900 614,041
2019-02-25 2019-02-21 4 CONE CyrusOne Inc.
Common Stock
A - Award 2,383 10,061 31.03
2018-06-14 2014-06-13 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
P - Purchase 4,000 117,315 3.53 12.52 50,080 1,468,784
2018-05-23 2018-05-21 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 15,949 113,315 16.38
2018-02-28 2018-02-26 4 CONE CyrusOne Inc.
Common Stock
A - Award 2,436 7,509 48.02
2017-05-24 2017-05-22 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 16,765 97,366 20.80
2017-02-15 2017-02-13 4 CONE CyrusOne Inc.
Common Stock
A - Award 2,597 5,022 107.09
2016-05-26 2016-05-24 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 15,129 80,601 23.11
2016-05-04 2016-05-02 4 CONE CyrusOne Inc.
Common Stock
A - Award 2,425 2,425
2016-05-04 3 CONE CyrusOne Inc.
No securities beneficially owned
0
2016-01-19 2016-01-15 4 PMCS PMC SIERRA INC
Common Stock
D - Sale to Issuer -16,015 0 -100.00
2015-12-07 2015-12-03 4 PMCS PMC SIERRA INC
Common Stock
S - Sale -44,701 16,015 -73.62 11.91 -532,389 190,739
2015-06-01 2015-05-29 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 14,215 65,472 27.73
2015-05-28 2015-05-26 4 PMCS PMC SIERRA INC
Common Stock
A - Award 6,821 60,716 12.66
2015-05-28 2015-05-26 4 PMCS PMC SIERRA INC
Common Stock
A - Award 16,015 53,895 42.28
2015-02-06 2015-02-04 4 PMCS PMC SIERRA INC
Common Stock
S - Sale -37,469 37,880 -49.73 9.05 -339,098 342,818
2015-02-05 2015-02-03 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise -41,698 0 -100.00
2015-02-05 2015-02-03 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise -41,023 0 -100.00
2015-02-05 2015-02-03 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise -55,845 0 -100.00
2015-02-05 2015-02-03 4 PMCS PMC SIERRA INC
Common Stock
S - Sale -15,000 75,349 -16.60 8.98 -134,775 677,011
2015-02-05 2015-02-03 4 PMCS PMC SIERRA INC
Common Stock
S - Sale -138,566 90,349 -60.53 8.97 -1,242,535 810,169
2015-02-05 2015-02-03 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 41,698 228,915 22.27 6.26 260,821 1,431,863
2015-02-05 2015-02-03 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 41,023 187,217 28.06 6.08 249,420 1,138,279
2015-02-05 2015-02-03 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 55,845 146,194 61.81 5.68 317,200 830,382
2014-11-24 2014-11-21 4 BYI BALLY TECHNOLOGIES, INC.
Common Stock, par value $.10 per share
U - Other -1,900 0 -100.00 83.30 -158,270
2014-11-12 2014-11-11 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
P - Purchase 5,000 51,257 10.81 11.26 56,300 577,154
2014-08-19 2014-08-18 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
P - Purchase 3,500 46,257 8.19 14.41 50,435 666,563
2014-07-03 2014-07-01 4 BYI BALLY TECHNOLOGIES, INC.
Common Stock, par value $.10 per share
A - Award 1,900 1,900
2014-07-03 3 BYI BALLY TECHNOLOGIES, INC.
Common Stock, par value $.10 per share
0
2014-05-29 2014-05-27 4 PMCS PMC SIERRA INC
Common Stock
A - Award 7,932 90,349 9.62
2014-05-29 2014-05-27 4 PMCS PMC SIERRA INC
Common Stock
A - Award 18,621 82,417 29.19
2014-05-27 2014-05-22 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 13,532 42,757 46.30
2013-08-19 2013-08-15 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
P - Purchase 10,000 24,225 70.30 14.80 148,000 358,530
2013-08-16 2013-08-15 4 PMCS PMC SIERRA INC
Common Stock
P - Purchase 15,000 63,796 30.74 6.26 93,900 399,363
2013-06-05 2013-06-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
A - Award 17,023 17,023
2013-06-05 2013-06-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
A - Award 24,000 24,000
2013-05-30 2013-05-28 4 PMCS PMC SIERRA INC
Common Stock
A - Award 3,905 48,796 8.70
2013-05-30 2013-05-28 4 PMCS PMC SIERRA INC
Common Stock
A - Award 10,187 44,891 29.35
2013-05-23 2013-05-21 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 14,225 14,225
2013-05-22 3 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
5,000
2013-01-02 2012-12-28 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -10,417 0 -100.00 4.55 -47,397
2013-01-02 2012-12-28 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
S - Sale -10,417 41,673 -20.00 5.27 -54,898 219,617
2013-01-02 2012-12-28 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
M - Exercise 10,417 52,090 25.00 4.55 47,397 237,010
2013-01-02 2012-12-20 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
G - Gift -25,000 3,277 -88.41
2012-12-20 2012-12-20 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
S - Sale -226,372 41,673 -84.45 5.48 -1,240,519 228,368
2012-12-20 2012-12-20 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
S - Sale -250,000 28,277 -89.84 5.48 -1,368,925 154,836
2012-12-20 2012-12-19 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -615,000 0 -100.00 3.38 -2,078,700
2012-12-20 2012-12-19 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
S - Sale -615,000 268,045 -69.65 5.46 -3,356,608 1,462,963
2012-12-20 2012-12-19 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
M - Exercise 615,000 883,045 229.44 3.38 2,078,700 2,984,692
2012-12-20 2012-12-19 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
S - Sale -240,835 268,045 -47.33 5.46 -1,313,972 1,462,427
2012-12-20 2012-12-19 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
S - Sale -250,000 278,277 -47.32 5.84 -1,460,850 1,626,084
2012-12-20 2012-12-18 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
S - Sale -250,000 528,277 -32.12 5.48 -1,370,275 2,895,539
2012-12-05 2012-12-03 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
J - Other 1,376 508,880 0.27 3.79 5,216 1,929,164
2012-11-05 2012-11-01 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Restricted Stock Units
M - Exercise -33,333 33,333 -50.00
2012-11-05 2012-11-01 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Restricted Stock Units
M - Exercise -37,666 0 -100.00
2012-11-05 2012-11-01 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Restricted Stock Units
M - Exercise -49,234 49,233 -50.00
2012-11-05 2012-11-01 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Restricted Stock Units
A - Award 98,467 98,467
2012-11-05 2012-11-01 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
F - Taxes -15,559 507,504 -2.97 5.48 -85,263 2,781,122
2012-11-05 2012-11-01 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
M - Exercise 33,333 523,063 6.81
2012-11-05 2012-11-01 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
F - Taxes -14,306 489,730 -2.84 5.48 -78,397 2,683,720
2012-11-05 2012-11-01 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
M - Exercise 37,666 504,036 8.08
2012-11-05 2012-11-01 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
F - Taxes -22,982 466,373 -4.70 5.48 -125,941 2,555,724
2012-11-05 2012-11-01 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
M - Exercise 49,234 489,355 11.19
2012-10-29 2012-10-25 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Restricted Stock Units
M - Exercise -50,000 100,000 -33.33
2012-10-29 2012-10-25 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
F - Taxes -18,340 440,118 -4.00 5.35 -98,119 2,354,631
2012-10-29 2012-10-25 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
M - Exercise 50,000 458,458 12.24
2012-06-14 2012-06-13 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
P - Purchase 60,000 778,277 8.35 4.50 269,760 3,499,133
2012-06-06 2012-06-05 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
A - Award 17,698 17,698
2012-06-06 2012-06-05 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
A - Award 24,000 24,000
2012-06-05 2012-06-05 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
P - Purchase 50,000 718,277 7.48 4.39 219,715 3,156,325
2012-06-04 2012-05-31 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
J - Other 3,750 408,458 0.93 3.95 14,822 1,614,430
2012-05-29 2012-05-25 4 PMCS PMC SIERRA INC
Common Stock
A - Award 3,838 34,704 12.43
2012-05-29 2012-05-25 4 PMCS PMC SIERRA INC
Common Stock
A - Award 9,361 30,866 43.53
2012-05-01 2012-04-29 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Restricted Stock Units
M - Exercise -100,000 0 -100.00
2012-05-01 2012-04-29 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
F - Taxes -36,680 404,708 -8.31 5.53 -202,840 2,238,035
2012-05-01 2012-04-29 4 BRCD BROCADE COMMUNICATIONS SYSTEMS INC
Common Stock
M - Exercise 100,000 441,388 29.29
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)